Summary
Amdipharm Mercury Company Ltd (AMCo), a subsidiary of Concordia Healthcare Corp. is an international pharmaceutical company that develops niche medicines. The company sells its products through four product ranges: Amdipharm, Mercury Pharma, Abcur and Focus. Some of its products include Acetazolamide, Adenosine, Adrenaline Acid Tartrate, Alfacalcidol, Aminophylline, Ampres, Anturn, Apresoline, Argipressin, Atropine Sulfate, Baratol, Bipuvacaine and Carbimazole among others. AMCo offers its products in various formulations such as tablets, injectables, eye drops and ointment. It sells its products through a network of distributors. The company has operations in India, Ireland, the UK, Sweden, Dubai and Australia. AMCo is headquartered in London, the UK.
Amdipharm Mercury Company Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Amdipharm Mercury Company Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Amdipharm Mercury Company Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Amdipharm Mercury Company Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Amdipharm Mercury Company Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Amdipharm Mercury Company Ltd, Medical Devices Deals, 2011 to YTD 2017 10
Amdipharm Mercury Company Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Amdipharm Mercury Company Ltd, Pharmaceuticals & Healthcare, Deal Details 12
Asset Purchase 12
Amdipharm Mercury Completes Acquisition Of Fucithalmic, Ophthalmic Medicine, From LEO Pharma 12
Private Equity 13
Cinven Acquires Mercury Pharma from HgCapital for USD730 Million 13
Acquisition 14
Concordia Healthcare Acquires Amdipharm Mercury for USD3.54 Billion 14
Amdipharm Mercury Acquires Boucher and Muir 16
Amdipharm Mercury acquires Primegen 17
Mercury Pharma Acquires Focus Pharma 18
Amdipharm Mercury Acquires Abcur, Specialty Pharma Company 18
Amdipharm Mercury Company Ltd - Key Competitors 20
Key Employees 21
Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24
List of Tables
Amdipharm Mercury Company Ltd, Pharmaceuticals & Healthcare, Key Facts, 2014 1
Amdipharm Mercury Company Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Amdipharm Mercury Company Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Amdipharm Mercury Company Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Amdipharm Mercury Company Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
Amdipharm Mercury Company Ltd, Medical Devices Deals, 2011 to YTD 2017 10
Amdipharm Mercury Company Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Amdipharm Mercury Completes Acquisition Of Fucithalmic, Ophthalmic Medicine, From LEO Pharma 12
Cinven Acquires Mercury Pharma from HgCapital for USD730 Million 13
Concordia Healthcare Acquires Amdipharm Mercury for USD3.54 Billion 14
Amdipharm Mercury Acquires Boucher and Muir 16
Amdipharm Mercury acquires Primegen 17
Mercury Pharma Acquires Focus Pharma 18
Amdipharm Mercury Acquires Abcur, Specialty Pharma Company 18
Amdipharm Mercury Company Ltd, Key Competitors 20
Amdipharm Mercury Company Ltd, Key Employees 21
Amdipharm Mercury Company Ltd, Other Locations 22
Amdipharm Mercury Company Ltd, Subsidiaries 22
List of Figures
Amdipharm Mercury Company Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1
Amdipharm Mercury Company Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1
Amdipharm Mercury Company Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1
Amdipharm Mercury Company Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1
Amdipharm Mercury Company Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Amdipharm Mercury Company Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
Amdipharm Mercury Company Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Amdipharm Mercury Company Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Amdipharm Mercury Company Ltd, Medical Devices Deals, 2011 to YTD 2017 10